scholarly journals The efficacy and safety of the biosimilar product (Inflectra®) compared to the reference drug (Remicade®) in rescue therapy in adult patients with ulcerative colitis

2017 ◽  
Vol 3 ◽  
pp. 169-174 ◽  
Author(s):  
Magdalena Kaniewska ◽  
Andrzej Moniuszko ◽  
Grażyna Rydzewska
Author(s):  
Sara Santos ◽  
Verónica Gamelas ◽  
Rita Saraiva ◽  
Guilherme Simões ◽  
Joana Saiote ◽  
...  

Tofacitinib has emerged as a new option for ulcerative colitis. Its rapid absorption, metabolism, and clinical improvement make it an interesting option for rescue therapy in acute severe ulcerative colitis (ASUC), a situation with limited therapeutic options in patients with a long-term disease course and multiple drug failure. The management of ASUC in this setting becomes challenging, underlying the need for new drugs and data on their efficacy and safety. We describe 2 cases of acute episodes in which tofacitinib was used as a rescue therapy.


2011 ◽  
Vol 45 (4) ◽  
pp. 380-381 ◽  
Author(s):  
Tamás Molnár ◽  
Klaudia Farkas ◽  
Tibor Nyári ◽  
Zoltán Szepes ◽  
Ferenc Nagy ◽  
...  

2010 ◽  
Vol 138 (5) ◽  
pp. S-688
Author(s):  
Maria Chaparro ◽  
Paula Burgueno ◽  
Eva Iglesias Flores ◽  
Julian Panes ◽  
Fernando Muñoz ◽  
...  

2010 ◽  
Vol 25 (5) ◽  
pp. 886-891 ◽  
Author(s):  
Shuji Yamamoto ◽  
Hiroshi Nakase ◽  
Minoru Matsuura ◽  
Yusuke Honzawa ◽  
Satohiro Masuda ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document